US Bancorp DE Has $187,000 Holdings in Transcat, Inc. (NASDAQ:TRNS)

US Bancorp DE raised its stake in Transcat, Inc. (NASDAQ:TRNS) by 15.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,547 shares of the scientific and technical instruments company’s stock after purchasing an additional 209 shares during the period. US Bancorp DE’s holdings in Transcat were worth $187,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Hood River Capital Management LLC grew its position in Transcat by 21.6% during the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock worth $23,558,000 after buying an additional 34,947 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after acquiring an additional 17,743 shares during the period. Raymond James & Associates lifted its position in shares of Transcat by 157.2% in the 3rd quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock worth $2,494,000 after acquiring an additional 12,622 shares during the period. Janus Henderson Group PLC grew its holdings in shares of Transcat by 208.3% during the 1st quarter. Janus Henderson Group PLC now owns 10,297 shares of the scientific and technical instruments company’s stock worth $1,147,000 after purchasing an additional 6,957 shares in the last quarter. Finally, Calamos Advisors LLC increased its position in shares of Transcat by 76.0% during the second quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock valued at $1,848,000 after purchasing an additional 6,667 shares during the period. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Trading Up 0.3 %

NASDAQ:TRNS opened at $108.03 on Friday. The stock has a market capitalization of $993.88 million, a P/E ratio of 54.56 and a beta of 0.69. Transcat, Inc. has a 1 year low of $89.39 and a 1 year high of $147.12. The firm has a 50 day moving average of $118.56 and a 200-day moving average of $121.68.

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The business had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. During the same quarter in the previous year, the company posted $0.41 EPS. Transcat’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, analysts forecast that Transcat, Inc. will post 1.76 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on TRNS shares. Northland Securities decreased their price target on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 30th. HC Wainwright reiterated a “buy” rating and set a $156.00 target price on shares of Transcat in a research report on Tuesday, October 29th. Craig Hallum dropped their price target on shares of Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a research report on Wednesday, October 30th. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $130.00 price target (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $127.25.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.